Abstract
Plasma YKL-40 is a new biomarker in patients with cancer and inflammatory diseases. High plasma YKL-40 is associated with poor prognosis. Our aim was to determine reference levels in healthy subjects.
Original language | English |
---|---|
Journal | Clinica chimica acta; international journal of clinical chemistry |
Volume | 412 |
Issue number | 9-10 |
Pages (from-to) | 709-12 |
Number of pages | 4 |
DOIs | |
Publication status | Published - 11 Apr 2011 |